Liu Z, Meng X, Zhang H, et al. Predicting distant metastasis and chemotherapy benefit in locally advanced rectal cancer. Nat Commun. 2020;11(1):4308.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Asoglu O, Bulut A, Aliyev V, Piozzi GN, Guven K, Bakır B, Goksel S. Chemoradiation and consolidation chemotherapy for rectal cancer provides a high rate of organ preservation with a very good long-term oncological outcome: a single-center cohort series. World J Surg Oncol. 2022;20(1):358.

Article  PubMed  PubMed Central  Google Scholar 

Shadmanov N, Aliyev V, Piozzi GN, Bakır B, Goksel S, Asoglu O. Perioperative and long-term oncological outcomes of robotic versus laparoscopic total mesorectal excision: a retrospective study of 672 patients. J Robot Surg. 2024;18(1):144.

Article  PubMed  Google Scholar 

Aliyev V, Piozzi GN, Bulut A, Guven K, Bakir B, Saglam S, Goksel S, Asoglu O. Robotic vs. laparoscopic intersphincteric resection for low rectal cancer: a case matched study reporting a median of 7-year long-term oncological and functional outcomes. Updates Surg. 2022;74(6):1851–60.

Article  PubMed  Google Scholar 

Jin J, Tang Y, Hu C, et al. Multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR). J Clin Oncol. 2022;40(15):1681–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Garcia-Aguilar J, Patil S, Gollub MJ, et al. Organ Preservation in Patients with Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy. J Clin Oncol. 2022;40(23):2546–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chatila WK, Kim JK, Walch H, Sauer R, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol. 2012;30:1926–33.

Article  Google Scholar 

Wang Y, Shen L, Wan J, et al. Neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer: a new era for anal preservation. Front Immunol. 2022;8(13):1067036.

Article  Google Scholar 

Saraf A, Roberts HJ, Wo JY, Parikh AR, et al. Optimal neoadjuvant strategies for locally advanced rectal cancer by risk assessment and tumor location. J Natl Compr Canc Netw. 2022;20(10):1177–84.

Article  CAS  PubMed  Google Scholar 

Bick RL. Coagulation abnormalities in malignancy: a review. Semin Thromb Hemost. 1992;18(4):353–72. https://doi.org/10.1055/s-2007-1002575.

Article  CAS  PubMed  Google Scholar 

Luzzatto G, Schafer AI. The prethrombotic state in cancer. Semin Oncol. 1990;17(2):147–59.

CAS  PubMed  Google Scholar 

Sun DZ, Liu L, Jiao JP, Wei PK, Jiang LD, Xu L. Syndrome characteristics of traditional Chinese medicine: summary of a clinical survey in 767 patients with gastric cancer. Zhong Xi Yi Jie He Xue Bao. 2010;8(4):332–40. https://doi.org/10.3736/jcim20100406.

Article  PubMed  Google Scholar 

Ay C, Dunkler D, Pirker R, Thaler J, Quehenberger P, Wagner O, et al. High D-dimer levels are associated with poor prognosis in cancer patients. Haematologica. 2012;97(8):1158–64. https://doi.org/10.3324/haematol.2011.054718.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lippi G, Franchini M, Targher G, Favaloro EJ. Help me, Doctor! My D-dimer is raised. Ann Med. 2008;40(8):594–605. https://doi.org/10.1080/07853890802161015.

Article  CAS  PubMed  Google Scholar 

Oya M, Akiyama Y, Okuyama T, Ishikawa H, et al. High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer. Jpn J Clin Oncol. 2001;31:388–94. https://doi.org/10.1093/jjco/hye075.

Article  CAS  PubMed  Google Scholar 

Knekt P, Hakulinen T, Leino A, Heliövaara M, Reunanen A, Stevens R. Serum albumin and colorectal cancer risk. Eur J Clin Nutr. 2000;54(6):460–2.

Article  CAS  PubMed  Google Scholar 

Lv L, Sun X, Liu B, et al. Genetically predicted serum albumin and risk of colorectal cancer: a bidirectional mendelian randomization study. Clin Epidemiol. 2022;21(14):771–8.

Article  Google Scholar 

Lin GS, Lu J, Lin J, et al. Value of the preoperative d-dimer to albumin ratio for survival and recurrence patterns in gastric cancer. Ann Surg Oncol. 2023;30(2):1132–44.

Article  PubMed  Google Scholar 

He S-S, Wang Y, Wang C-T, et al. A combined marker based on plasma D-dimer and serum albumin levels in patients with nasopharyngeal carcinoma is associated with poor survival outcomes in a retrospective cohort study. J Cancer. 2019;10(16):3691–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Benson AB, Venook AP, Al-Hawary MM, Arain MA, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Garrido-Laguna I, Grem JL, Gunn A, Hoffe S, Hubbard J, Hunt S, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Miller ED, Mulcahy MF, Nurkin S, Overman MJ, Parikh A, Patel H, Pedersen K, Saltz L, Schneider C, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Johnson-Chilla A, Gurski LA. NCCN guidelines insights: rectal cancer, version 6.2020. J Natl Compr Canc Netw. 2020;18(7):806–15.

Article  PubMed  Google Scholar 

Desch A, Gebhardt C, Utikal J, Schneider SW, et al. D-dimers inmalignant melanoma: association with prognosis and dynamic variation in disease progress. Int J Cancer. 2017;140(4):914–21.

Article  CAS  PubMed  Google Scholar 

Kilic L, Yildiz I, Sen FK, Erdem MG, Serilmez M, Keskin S, Ciftci R, Karabulut S, Ordu C, Duranyildiz D, Tas F. D-dimer and international normalized ratio (INR) are correlated with tumor markers and disease stage in colorectal cancer patients. Cancer Biomark. 2015;15(4):405–11.

Article  CAS  PubMed  Google Scholar 

Bikdeli B, Sharif-Kashani B, Chitsaz E, et al. Dexter versus sinister deep vein thrombosis: which is the more sinister? findings from the NRITLD DVT registry. Sem Orombosis Hemostasis. 2011;37(3):298–304.

Article  Google Scholar 

Kwaan HC, Lindholm PF, et al. Fibrin and fibrinolysis in cancer. Sem Orombosis Hemostasis. 2019;45(4):413–22.

Article  CAS  Google Scholar 

Dai H, Zhou H, Sun Y, et al. D-dimer as a potential clinical marker for predicting metastasis and progression in cancer. Biomed Rep. 2018;9(5):453–7.

PubMed  PubMed Central  Google Scholar 

Edwards CM, Warren J, Armstrong L, et al. D-dimer: a useful marker of disease stage in surgery for colorectal cancer. Br J Surg. 1993;80(11):1404–5.

Article  CAS  PubMed  Google Scholar 

Motavaf E, Sunesen KG, Stender MT, et al. Prognostic value of preoperative D-dimer and carcinoembryonic antigen levels in patients undergoing intended curative resection for colorectal cancer: a prospective cohort study. Int J Colorectal Dis. 2014;29(11):1427–32.

Article  PubMed  Google Scholar 

Kilic M, Yoldas O, Keskek M, et al. Prognostic value of plasma D-dimer levels in patients with colorectal cancer. Colorectal Dis. 2008;10(3):238–41.

Article  CAS  PubMed  Google Scholar 

Xu G, Zhang YL, Huang W, et al. Relationship between plasma D-dimer levels and clinicopathologic parameters in resectable colorectal cancer patients. World J Gastroenterol. 2004;10(6):922–3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mochizuki S, Yoshino T, Kojima T, et al. Therapeutic significance of a D-dimer cut-off level of >3 µg/ml in colorectal cancer patients treated with standard chemotherapy plus bevacizumab. Jpn J Clin Oncol. 2010;40(10):933–7.

Article  PubMed  Google Scholar 

Wu B, Zhang G, Zhao X, Wang J, Wang D, Zhang Y, Yu M, Cai H. Assessment of the association between D-dimer levels and clinicopathological characteristics of pancreatic cancer and its role in prognosis: a systematic review and meta-analysis. Asian J Surg. 2024;S1015–9584(24):00301–4.

Google Scholar 

Wiedermann CJ. Hypoalbuminemia as surrogate and culprit of infections. Int J Mol Sci. 2021;22(9):4496.

Article